Alprazolam Related Clinical Trials
Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet [Completed]
Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation [Withdrawn]
Bioequivalence of Alprazolam Sublingual vs Oral Tablets [Completed]
A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions [Withdrawn]
Staccato® Alprazolam and EEG Photoparoxysmal Response [Recruiting]
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions [Completed]
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions [Completed]
PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam) [Completed]
Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation [Withdrawn]
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets [Completed]
Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation [Withdrawn]
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions [Completed]
A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions [Completed]
A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions [Completed]
Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population [Completed]
Bioequivalence Trial of Alprazolam 0.25 mg Tablets [Completed]
Bioequivalence Trial of Alprazolam 0.5 mg Tablets [Completed]
Bioequivalence Trial of Alprazolam 2 mg Tablets [Completed]
Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block [Completed]
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites [Completed]
Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment [Completed]
A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks [Terminated]
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions [Completed]
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions [Completed]
A Study to Assess the Long-Term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder [Terminated]
Abuse Liability of Staccato Alprazolam [Completed]
Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy [Completed]
A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder [Terminated]
Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T [Recruiting]
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg [Completed]
A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets [Completed]
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2 [Active, not recruiting]
Fed Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg [Completed]
Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg [Completed]
Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg [Completed]
Staccato� Alprazolam for Inhalation in Panic Disorder [Completed]
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg [Completed]
A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder [Completed]
Spectroscopic Imaging at 4T: A Drug Challenge Study [Completed]
Alprazolam and Eating Behavior in Anorexia Nervosa [Completed]
A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety [Completed]
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure [Completed]
A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients [Completed]
A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder [Completed]
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users [Completed]
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones. [Completed]
Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder [Recruiting]
Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2 [Completed]
Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects [Terminated]
Reassessment of Premedication in Surgery [Completed]
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. [Completed]
Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety [Completed]
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD [Completed]
A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects [Completed]
Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder [Withdrawn]
Pharmacovigilance in Gerontopsychiatric Patients [Recruiting]
Gabapentin Treatment of Benzodiazepine Dependence [Recruiting]
Psychopharmacology of Fear-Potentiated Startle in Humans [Completed]
MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL) [Completed]
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers [Completed]
Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions [Recruiting]
Effects of Hallucinogens and Other Drugs on Mood and Performance [Recruiting]
Clarithromycin for the Treatment of Hypersomnia [Completed]
Flumazenil for the Treatment of Primary Hypersomnia [Completed]
ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder [Completed]
|